Institutional Biosafety Committee
The University is committed to maintaining a safe and healthy environment for its students, faculty, staff, and visitors. Research and teaching activities involving biological materials must be conducted in a manner that protects laboratory personnel, the public, and the environment while ensuring compliance with applicable federal, state, and institutional regulations.
The Institutional Biosafety Committee (IBC) provides oversight for research and institutional
activities involving biological hazards and recombinant or synthetic nucleic acid
molecules conducted at or sponsored by the university. The IBC ensures that such activities
are conducted safely and in accordance with NIH Guidelines for Research Involving
Recombinant or Synthetic Nucleic Acid Molecules, the CDC/NIH Biosafety in Microbiological
and Biomedical Laboratories (BMBL) guidance, and other applicable federal, state,
and institutional regulations.
The IBC serves as a forum where biosafety issues, risks, and compliance matters related
to biological research can be reviewed collaboratively. The committee works closely
with Environmental Health and Safety (EHS), the Office of Research and Economic Development
(ORED), and other institutional oversight committees to ensure safe research practice
and regulatory compliance.
- Procedures
- Membership Roster
2026 - 2027 Roster
- Minutes